Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Signs on New Batch of Academics for RNAi Partnership Program

NEW YORK (GenomeWeb News) – Sigma-Aldrich said today that researchers from six academic institutions have joined its RNAi Partnership Program.
 
The researchers are from The Wistar Institute, Mayo Clinic, Tufts University, Princeton University, the Moores Cancer Center at the University of California, San Diego, and Washington University in St. Louis.
 
Sigma formed its RNAi Partnership Program in April to provide researchers with RNAi tools, including products, new technologies, and reagents, as well as access to Sigma-Aldrich’s functional genomic portfolio.
 
The portfolio includes access to the lentivirus-based MISSION TRC shRNA libraries that target more than 15,000 human and mouse genes.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.